Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.
about
Generation of diverse neural cell types through direct conversionRole of Epigenetics in Stem Cell Proliferation and Differentiation: Implications for Treating Neurodegenerative DiseasesAlzheimer's Disease: Mechanism and Approach to Cell TherapyErythropoietin facilitates the recruitment of bone marrow mesenchymal stem cells to sites of spinal cord injury.Analgesia for neuropathic pain by dorsal root ganglion transplantation of genetically engineered mesenchymal stem cells: initial results.Stem cells for cell replacement therapy: a therapeutic strategy for HD?Manipulation of a quasi-natural cell block for high-efficiency transplantation of adherent somatic cells.A possible new focus for stroke treatment - migrating stem cellsMesenchymal Stem Cells from Human Extra Ocular Muscle Harbor Neuroectodermal Differentiation Potential.Sustained expression of coagulation factor IX by modified cord blood-derived mesenchymal stromal cells.Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.Comparative Study on the Differentiation of Mesenchymal Stem Cells Between Fetal and Postnatal Rat Spinal Cord Niche.Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases.Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis.Neuroprotective Effect of the LRRK2 Kinase Inhibitor PF-06447475 in Human Nerve-Like Differentiated Cells Exposed to Oxidative Stress Stimuli: Implications for Parkinson's Disease.Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases.Translation of cell therapies to the clinic: characteristics of cell suspensions in large-diameter injection cannulae.
P2860
Q26765258-AA6D2F4B-0CBD-4718-997B-07425080F22EQ26768645-ADAD429B-DD47-4823-93D3-437918CD8D2FQ26778149-FEAB408D-1432-4C76-B873-07C02091B42DQ33723789-E22AADF5-4406-43D8-8297-6C820B90AE5AQ35091885-90D8A553-DF1A-4CA9-887D-D597F17C29DEQ35250495-B6E69B68-2025-499E-B829-703DD67BF08FQ35653445-EA57EF22-24EA-45FF-BE3E-04A6E71F200BQ35738018-C98DEF82-E0BD-4143-8505-FD81D7E4B1D9Q36036209-E091786E-3908-4F0C-8437-C59C21AE916AQ38982780-3438B5D1-CB07-4B68-A1A2-0123916C37EDQ38999345-855B7A62-5EB3-45EA-A6D7-2E641B946E78Q40228101-FB5B5715-A555-4B7A-B9E3-AC0E2E0A3D79Q40686919-7072F513-EAAA-40EE-9955-E212751A5311Q41572871-C5889086-6D4D-42C8-9099-9CE08C6CA9DDQ45862169-F147E306-8599-4542-A56F-AB96BC2DBE0FQ46520584-D04BD2F4-FDD1-4B8C-9542-DDF19544DF7CQ47941437-74875411-75B5-4D05-A9DB-1B5C08CBF287Q48456297-747B2C85-F1FB-43B3-B159-170035F35640
P2860
Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.
@en
type
label
Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.
@en
prefLabel
Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.
@en
P2860
P921
P356
P1476
Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.
@en
P2093
Gary L Dunbar
Robert D Wyse
P2860
P304
P356
10.3390/IJMS15021719
P407
P5008
P577
2014-01-23T00:00:00Z